Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas

Published:2018-09 Issue:3 Volume:150 Page:534-544
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bi Yue,Verginadis Ioannis I.,Dey Souvik,Lin Lilie,Guo Linlang,Zheng Yanfang,Koumenis Constantinos

Funder

Kaleidoscope of Hope Foundation

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference46 articles.

1. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential;Luvero;Ther. Adv. Med. Oncol.,2014

2. Ovarian cancer;Jayson;Lancet,2014

3. A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients;Yan;Clin. Oncol. (R. Coll. Radiol.),2011

4. Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival;Teckie;Radiat. Oncol. (London, England),2013

5. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure;Corn;Cancer,1994

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer;Clinical and Translational Radiation Oncology;2024-07

3. Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi);International Journal of Gynecologic Cancer;2024-05-31

4. A perspective on tumor radiation resistance following high-LET radiation treatment;Journal of Cancer Research and Clinical Oncology;2024-05-02

5. Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed;Health and Technology;2024-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3